This work was done to identify some of the plants used in the treatment of malaria in Uganda and to investigate their efficacy in the in-vifro assays. Plumbago zeylenica and Cryptolepis sanguinolenm showetl marked activity on the chloroquine resistant and chloroquine sensitive strains of Plnsmorlium falcipnrum. Plumbagin, a quinone, mas isolated from Plumbflgo zeylenicn, ant1 fount1 to have antimalarial activity with ICSo of 178 nglml on cllloroquine sensitive and 188 nglml on chloroquine resistant strains. Cytotoxicity assays on KB cell lines indicated that the extract was selective for Plrc~morlicinz fnlciyarunr. The Selective Index was 5 in both strains of Plmmodium frrlciparunt.
INTRODUCTION
Malaria is the niost important public health problem in Uganda. It accounts for 25 % of patient attendances, 20 % adtnissiolis and 15 % in-patient deaths [I] . Children belo\,\ 5 years and pregnant women are the most severely affected by the disease. Malaria is becoming increasingly difficult to control because the parasites are rapidly developing resistance to tlie available drugs [2] . Therefore, there is ilrgerit need for new drugs with novel modes of action. The drugs are also not readily accessible to tlie coni~ni~nity due to the low socio-economic status and the poor distribution of health facilities. This has led to extensive use of herbal remedies for treatment of diseases including malaria.
The traditional healers in Uganda recognized tlie ~nedicinal value of plants and ilsecl them for treatment of various ailments, including fever, possibly due to malaria [3] . Plants that are extensively used in Uganda for treatment of fevers I 
Extraction
Dry powdered plant material (300 g) was extracted by soaking in chloroform (500 ml) for 24 11 with occasional shaking. The solvent was removed using a rotary evaporator to afford * Author to whom correspondence may be addressed. 34 Ogwal-Okeng et a/. -East and Cent. Afr. J. Pharm. Sci. 5(2002) semisolid extracts.
Bioassay-guided fractionntion of P. zeylenicn
The chloroform extract of P. zeylenica demonstrated the highest antiplasniodial activity (ICjo 1375.0 and 4642.0 idn nil on chloroquinesensitive (D6) and cliloroquine-resigta~it (W2) strains, respectively) and was therefore selected for further fractionation. Tlie cri~de extract (3.5 g) was fractionated by column clironiatograpliy on silica gel. The column was eluted with petroleum ether followed by increasing concentrations of chloroform, acetone and methanol in petroleum ether, then finally washed with methanol. The eluents were examined by thin layer chromatography and fractions with similar Rf values combined to give 27 fractions (F 1 -F27). Antimalarial bioassay test located tlie highest activity in fraction 4. Tlie bioaclive fraction was purified by recrystallisation from melliauol to give an orange crystalline compound (1. l mg. 0.36 %). The compound was verified to be 5-hydroxy-2-methq I-l.4-1iapIithoqt1i1ione, plumbagin (figure I), bq comparing tlie physical (TLC, Rf \,slue, HPLC retention time and melting point) and spectroscopic (UV, IR, IMS and SXIR) data witli those of authentic sample.
Bioassays
Antimalarial bioassay tests were ilsed to select the active chlorofor~n extract and to follow the active fraction during the fractionation of P. zeylenica extract. Ii? vilro cytotoxicity assay was performed to determine the level of toxicity and selectivity of plumbagiti.
Antima1ari;ll Assays
Antimalarial activity of the crude extracts and plumbagin was assessed using the in vitro radioisotope-incorporation ~netliod [ 8 ] as modified by Likliitwitayawuid et uI. [9] . The tests were done using suspensionsf chloroqi~ine-resistant (W2) and chloroquine-sensitive (D6) P. falciparuil~ infected red blood' cells (0.6 % parasitaemia, 1 % cell Iiaeniatocrit). The materials were tested over a concentration range of 14 -10,000 ng/ml in 96-well microtitre plates. Control experiments were similarly set with culti~re medium (RPMI-1640, GIBCO, Chicago, U.S.A.) as tlie drug-free control. Chloroqiline was used as a positive control antimalarial drug.
Tlie niicrotitre plates were incubated for 24 11 at 37 "C in a sealed chamber in an atniosphere of 5 % COz, 5 % O2 and 90 % Nz. After tlie incubation, 0.5 yCi of [3~]hypoxantliine (New England Nuclear, Boston, U.S.A.) was added to each well, and the plate returned to tlie sealed cliatnber at 37 "C for another 18 11. Tlie contents of the micro wells were then harvested into a glass fibre filta~nat (Filtermat A), (Wallac Oy. Tul-kit Finland) using a Tomtec 96-well Iiarvestei-(Tonitec, Orange, Connecticut, U.S.A.). Filtermats were dried, immersed in 4 ml scintillation fluid in a sealed plastic pouch. Radioactivity in each well was counted usin_g 1450 ~i c r o~e t a~~ Liquid Scintillation Counter (Wallac Oy). Tlie concentration that inhibited parasite-specific incorporation of ['~]li~~oxantliine by 50 % (ICjo) was deterniined by lion-linear regressio~i analysis. The drug-free control defined tlie 100 % incorporation of tlie radioact ivit~..
.Assays for Cytotoxicity
Plumbagin was evaluated for le\el of tosicit! and degree of selectivity for Plastnodizr~~~ !;71~1~)tn.~/n1 by the in vitro cytotoxicity test, using the Iluman oral epidermoid carcinoma (KB) cell lines and stained with sulforliodamine B (SRB assay) as described by Skehan er al. [lo] . Tlie cell culture (KB) was incubated witli plumbagin at concentrations ranging from 0.16-20 pg/~nl, i n 96-well microtitre plates, for 72 h. Cell growth was assessed by measuring tlie cellular protein content using Sulforhodamine B. After removing the unbound dye with 1 % acetic acid, proteinbound dye was extracted witli 10 m M unbuffered Tris base (pH 10) and the optical density (OD) was measured at 515 nm using ELlSA plate reader. The TC50 was calculated using lion-linear regression analysis (percent survival vs. concentration). Tlie Selective Index (SI) was therefore determined as a ratio of TCso to ICjo. 
RESULTS AND DISCUSSIONS
The plants screened for antimalarial activities are presented in table 1. Activity was defined as IC50 value of 55000 ng/nil. P. zeylenica extract demonstrated the highest activity, the ICso was found to be 4642 ndml and 1375 ndnil on W2 and D6 parasites, respectively. C. snnguinolenta also demonstrated antimalarial activity, especially on D6 strain (IC50 = 2772.9 nghnl), but poor activity against W2 strain. C. clependens, H. abyssinica, S. pinnata and S. ujricana had minimal activity on the tested strains. This might mean that the plants have no antimalarial effect or may act as antipyretics or immune modulators. It is also possible that the active compound exists as pro-drug that may need biotransformation in vivo to the active form. This study also confirmed the findings of other authors that Ilavc isolated cryptolepine, a very potent antimalarial compound from C. sungzrinolenta [I I , 121.
The active compound isolated from P. zeylenica was determined to be 5-hydroxy-2-methyl-1, 4-naphthoquinone with the con~mon name plumbagin (figure 1) and its antimalarial and cytotoxicity is shown in table 2. The KB cell line is used to determine the selectivity of a compound and discriminate compounds that selectively inhibit Plasmodium and hence act as general toxins. It was therefore used to define the in vitro therapeutic index, in this case referred to as the "Selective Index". SI for antimalarial activity is therefore defined as the ratio of tlie medium toxic dose in the KB cell lines (TC-50 [KB] ) to the medium inhibitory concentration in P. fulciparurn (ICso [P. falciparurtz]). The S I serves as an in vitro indicator of clinical safety in the absence of the in vivo therapeutic index. SI is therefore used to prioritize active test samples, and in guiding bioassaydirected fractionation [I 3, 141. Plumbagin showed high activity against both chloroquine sensitive and resistant strains of the parasite. The cytotoxicity value of 1000.00 ng/ml gave tlie selective index (SI) of 5.5 and 5.3 on D6 and W2 parasites, respectively. The compound was therefore more than five t.imes selective for the malaria parasites ( 5(2002) The antimalarial activities of naplithoquinones and quinone-containing colnpounds have been known for a long time [15] . Plumbagin was first isolated from Plumbago scandeiu by workers in Brazil who were investigating the plant for its anti-inflammatory and anti-Parkinsonian effects [16] . Likhitwitayawuid et al. reported isolation of plumbagin from Nepenthes thorelli (Nepenthaceae), investigated its structure-activity relationships and concluded that the quinone structure was essential for the antimalarial activity of the compound [9] . It has been suggested that plumbagin produces antimalarial action by inhibiting the mitochondria1 NADH dehydrogenase [I 7, 181. This study has been able to justify the use of some of these plants as antimalarial drugs by the traditional healers in Uganda. It confirms that tlie plants contain compounds that can inhibit multiplication of the parasites and therefore act as drugs for the treatment of malaria. The study has also demonstrated that plumbagin is selective for the malaria parasites and can be used safely as an antimalarial drug.
The problem of using herbs has been the validation of efficacy, safety and quality control of the preparations. This study has demonstrated the antiplasmodial eficacy of the extracts of C. sanguinolenta and P. zeylenica as well as the antimalarial efficacy and safety of plumbagin. It will now be possible to standardize and control the quality of the herbal preparations of P. zeylenica and therefore improve the management of malaria in the community.
CONCLUSION
The result of this study was fed back to the traditional healers in a workshop. Plumbagin will be used to standardize and control the quality of the herbal preparations of P. zeylenica. The healers agreed to participate in a clinical trial of the standardized herbal preparations, including P. zeylenica.
